Physician profile
Patrick Leung
NPI 1811335748
$7,869.85
in general payments reported to CMS, 2019-2025
9 companies · $666 in 2025
The $666 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,059 · 2020: $183 · 2021: $1,307 · 2022: $816 · 2023: $456 · 2024: $383 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,058.46 | 2019-2025 | Mako |
| Smith+Nephew, INC. | $364.19 | 2019 | |
| Abbvie INC. | $135.99 | 2022 | |
| Zimmer Biomet Holdings, INC. | $116.36 | 2019-2024 | G7 |
| Djo, LLC | $86.07 | 2024 | Cmf |
| Orthosensor INC. | $34.74 | 2020 | |
| Kerecis Limited | $31.54 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.15 | 2025 | Jardiance |
| Horizon Therapeutics Plc | $18.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.